IGC Pharma
IGC
#10698
Rank
ยฃ19.39 M
Marketcap
ยฃ0.19
Share price
1.59%
Change (1 day)
-40.51%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

IGC Pharma (IGC) - Cash on Hand

Cash on Hand as of March 2026 : ยฃ0.17 Million

According to IGC Pharma's latest financial reports the company has ยฃ0.17 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

IGC Pharma - Cash on Hand chart (from 2006 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31ยฃ0.31 M-66.94%
2024-03-31ยฃ0.94 M-65.06%
2023-03-31ยฃ2.71 M-65.9%
2022-03-31ยฃ7.95 M-25.02%
2021-03-31ยฃ10.61 M6.7%
2020-03-31ยฃ9.94 M-49.43%
2019-03-31ยฃ19.66 M1565.06%
2018-03-31ยฃ1.18 M-38.74%
2017-03-31ยฃ1.92 M85.81%
2016-03-31ยฃ1.03 M86.62%
2015-03-31ยฃ0.55 M-9.74%
2014-03-31ยฃ0.61 M-12.07%
2013-03-31ยฃ0.7 M99.03%
2012-03-31ยฃ0.35 M-64.36%
2011-03-31ยฃ0.98 M79.14%
2010-03-31ยฃ0.55 M-62.57%
2009-03-31ยฃ1.47 M-74.05%
2008-03-31ยฃ5.67 M-83.45%
2007-03-31ยฃ34.27 M-10%
2006-03-31ยฃ38.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sterling Infrastructure
STRL
ยฃ0.34 B 197,538.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
ยฃ0.11 B 66,155.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
ยฃ0.78 B 444,610.64%๐Ÿ‡บ๐Ÿ‡ธ USA